EKSO BIONICS HOLDINGS, INC.EKSOEarnings & Financial Report
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis (MS) or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
EKSO Q4 FY2025 Key Financial Metrics
Revenue
$3.1M
Gross Profit
$1.7M
Operating Profit
$-4.5M
Net Profit
$-4.7M
Gross Margin
53.2%
Operating Margin
-143.6%
Net Margin
-148.9%
YoY Growth
-38.3%
EPS
$-3.01
EKSO BIONICS HOLDINGS, INC. Q4 FY2025 Financial Summary
EKSO BIONICS HOLDINGS, INC. reported revenue of $3.1M (down 38.3% YoY) for Q4 FY2025, with a net profit of $-4.7M (down 36.9% YoY) (-148.9% margin). Cost of goods sold was $1.5M, operating expenses totaled $6.2M.
Key Financial Metrics
| Total Revenue | $3.1M |
|---|---|
| Net Profit | $-4.7M |
| Gross Margin | 53.2% |
| Operating Margin | -143.6% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
EKSO BIONICS HOLDINGS, INC. Q4 FY2025 revenue of $3.1M breaks down across 2 segments, led by Products at $2.3M (74.6% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Products | $2.3M | 74.6% |
| Other | $799.0K | 25.4% |
EKSO BIONICS HOLDINGS, INC. Revenue by Segment — Quarterly Trend
EKSO BIONICS HOLDINGS, INC. revenue by segment across the last 4 reported quarters, showing how each business line (such as Products and Other) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Products | $2.3M | $3.2M | $1.2M | $2.5M |
| Other | $799.0K | $986.0K | $885.0K | $888.0K |
EKSO BIONICS HOLDINGS, INC. Annual Revenue by Year
EKSO BIONICS HOLDINGS, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $12.8M).
EKSO BIONICS HOLDINGS, INC. Quarterly Revenue & Net Profit History
EKSO BIONICS HOLDINGS, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $3.1M | -38.3% | $-4.7M | -148.9% |
| Q3 FY2025 | $4.2M | +2.4% | $-1.4M | -33.6% |
| Q2 FY2025 | $2.1M | -58.4% | $-2.7M | -131.7% |
| Q1 FY2025 | $3.4M | -10.1% | $-2.9M | -85.7% |
| Q4 FY2024 | $5.1M | +5.0% | $-3.4M | -67.1% |
| Q3 FY2024 | $4.1M | -10.4% | $-2.1M | -50.2% |
| Q2 FY2024 | $5.0M | +5.3% | $-2.4M | -48.8% |
| Q1 FY2024 | $3.8M | -8.9% | $-3.4M | -91.3% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8M | $5.0M | $4.1M | $5.1M | $3.4M | $2.1M | $4.2M | $3.1M |
| YoY Growth | -8.9% | 5.3% | -10.4% | 5.0% | -10.1% | -58.4% | 2.4% | -38.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $29.0M | $27.0M | $29.2M | $26.7M | $27.3M | $23.2M | $21.7M | $20.1M |
| Liabilities | $14.9M | $14.9M | $14.3M | $13.9M | $14.6M | $12.2M | $12.0M | $11.1M |
| Equity | $14.1M | $12.1M | $14.9M | $12.7M | $12.7M | $10.9M | $9.7M | $9.0M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-3.5M | $-2.7M | $-2.3M | $-1.4M | $-2.0M | $-3.4M | $-2.1M | $-4.3M |